Asker Healthcare Group (ASKER) Stock Overview
Provides medical supplies, devices, and equipment and related solutions that support patient care. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ASKER Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Asker Healthcare Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 80.35 |
| 52 Week High | SEK 105.48 |
| 52 Week Low | SEK 58.64 |
| Beta | 0 |
| 1 Month Change | -2.19% |
| 3 Month Change | 0.88% |
| 1 Year Change | -18.24% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -4.00% |
Recent News & Updates
Recent updates
Outsourced Logistics And Preparedness Services Will Support A Stronger Long Term Outlook
Catalysts About Asker Healthcare Group Asker Healthcare Group supplies medical consumables, equipment and related services to healthcare providers across 19 countries through a network of around 70 companies. What are the underlying business or industry changes driving this perspective?Asker Healthcare Group's (STO:ASKER) Solid Earnings Are Supported By Other Strong Factors
Asker Healthcare Group AB (publ) ( STO:ASKER ) recently posted some strong earnings, and the market responded...Asker Healthcare Group AB Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next
There's been a notable change in appetite for Asker Healthcare Group AB ( STO:ASKER ) shares in the week since its...Investors Interested In Asker Healthcare Group AB's (STO:ASKER) Earnings
Asker Healthcare Group AB's ( STO:ASKER ) price-to-earnings (or "P/E") ratio of 59.6x might make it look like a strong...We Think Asker Healthcare Group (STO:ASKER) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Asker Healthcare Group AB's (STO:ASKER) Intrinsic Value Is Potentially 32% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Asker Healthcare Group fair value estimate is kr111 Asker...We Think Asker Healthcare Group (STO:ASKER) Can Stay On Top Of Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Asker Healthcare Group's (STO:ASKER) Solid Earnings Are Supported By Other Strong Factors
Asker Healthcare Group AB ( STO:ASKER ) just reported healthy earnings but the stock price didn't move much. Our...Shareholder Returns
| ASKER | SE Healthcare | SE Market | |
|---|---|---|---|
| 7D | -5.1% | -3.4% | -1.1% |
| 1Y | -18.2% | -6.6% | 12.6% |
Return vs Industry: ASKER underperformed the Swedish Healthcare industry which returned -6.6% over the past year.
Return vs Market: ASKER underperformed the Swedish Market which returned 12.6% over the past year.
Price Volatility
| ASKER volatility | |
|---|---|
| ASKER Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 5.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in SE Market | 11.3% |
| 10% least volatile stocks in SE Market | 3.1% |
Stable Share Price: ASKER has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: ASKER's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 4,885 | Johan Falk | www.asker.com |
Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics; defibrillators and wound care products. In addition, it develops and sells disposable medical supplies under the Evercare, Selefa, and Embra brands; distributes eye surgery products; and develops and sells products for time-management, communication, and cognition for schools, assistive technology centres, and other public services.
Asker Healthcare Group AB (publ) Fundamentals Summary
| ASKER fundamental statistics | |
|---|---|
| Market cap | SEK 30.45b |
| Earnings (TTM) | SEK 715.00m |
| Revenue (TTM) | SEK 18.01b |
Is ASKER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASKER income statement (TTM) | |
|---|---|
| Revenue | SEK 18.01b |
| Cost of Revenue | SEK 10.57b |
| Gross Profit | SEK 7.44b |
| Other Expenses | SEK 6.73b |
| Earnings | SEK 715.00m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
Nov 04, 2026
| Earnings per share (EPS) | 1.87 |
| Gross Margin | 41.32% |
| Net Profit Margin | 3.97% |
| Debt/Equity Ratio | 77.0% |
How did ASKER perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/14 17:56 |
| End of Day Share Price | 2026/08/14 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Asker Healthcare Group AB (publ) is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christoph Blieffert | BNP Paribas |
| null null | Danske Bank |
| Erik Cassel | Danske Bank |